Russia's Sputnik V Vaccine Destined For EU Markets
The Russian Direct Investment Fund has applied for authorization of Russia’s Sputnik V coronavirus vaccine in the European Union, the state-run RIA Novosti news agency reported yesterday. The European Medicines Agency (EMA) has concluded a scientific opinion procedure for the vaccine developers on January 19 this year and is due to begin the formal approval[.....]